Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes

Songcang Chen, Miklos Garami, David G. Gardner

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Doxorubicin is an antineoplastic agent with significant cardiotoxicity. We examined the effects of this agent on the expression of the natriuretic peptide (NP) genes in cultured neonatal rat atrial myocytes. Doxorubicin suppressed NP secretion, steady-state NP mRNA levels, and NP gene promoter activity. In each instance, brain NP (BNP) proved to be more sensitive than atrial NP (ANP) to the inhibitory effects of the drug. ICRF-187 and probucol reversed the inhibition by doxorubicin of ANP mRNA accumulation and ANP gene promoter activity while exerting no effect on BNP mRNA levels or promoter activity. This represents the first identification of the NP genes as targets of doxorubicin toxicity in the myocardial cell. This inhibition operates predominantly at a transcriptional locus and has more potent effects on BNP versus ANP secretion/gene expression. Measurement of BNP secretion/gene expression may provide a sensitive marker of early doxorubicin cardiotoxicity.

Original languageEnglish
Pages (from-to)1223-1231
Number of pages9
JournalHypertension
Volume34
Issue number6
DOIs
Publication statusPublished - Dec 1999

Keywords

  • Cardiomyopathies
  • Doxorubicin
  • Hypertrophy
  • Natriuretic peptides

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Doxorubicin selectively inhibits brain versus atrial natriuretic peptide gene expression in cultured neonatal rat myocytes'. Together they form a unique fingerprint.

  • Cite this